TY  - JOUR
AU  - Duruisseaux, Michäel
AU  - Martinez-Cardus, Anna
AU  - Calleja-Cervantes, Maria E
AU  - Moran, Sebastian
AU  - Castro-de-Moura, Manuel
AU  - Davalos, Veronica
AU  - Piñeyro, David
AU  - Sanchez-Cespedes, Montse
AU  - Girard, Nicolas
AU  - Brevet, Marie
AU  - Giroux-Leprieur, Etienne
AU  - Dumenil, Coraline
AU  - Pradotto, Monica
AU  - Bironzo, Paolo
AU  - Capelletto, Enrica
AU  - Novello, Silvia
AU  - Cortot, Alexis
AU  - Copin, Marie-Christine
AU  - Karachaliou, Niki
AU  - Gonzalez-Cao, Maria
AU  - Peralta, Sergio
AU  - Montuenga, Luis M
AU  - Gil-Bazo, Ignacio
AU  - Baraibar, Iosune
AU  - Lozano, Maria D
AU  - Varela, Mar
AU  - Ruffinelli, Jose C
AU  - Palmero, Ramon
AU  - Nadal, Ernest
AU  - Moran, Teresa
AU  - Perez, Lidia
AU  - Ramos, Immaculada
AU  - Xiao, Qingyang
AU  - Fernandez, Agustin F
AU  - Fraga, Mario F
AU  - Gut, Marta
AU  - Gut, Ivo
AU  - Teixidó, Cristina
AU  - Vilariño, Noelia
AU  - Prat, Aleix
AU  - Reguart, Noemi
AU  - Benito, Amparo
AU  - Garrido, Pilar
AU  - Barragan, Isabel
AU  - Emile, Jean-François
AU  - Rosell, Rafael
AU  - Brambilla, Elisabeth
AU  - Esteller, Manel
PY  - 2018
DO  - 10.1016/S2213-2600(18)30284-4
UR  - http://hdl.handle.net/10668/12826
T2  - The Lancet. Respiratory medicine
AB  - Anti-programmed death-1 (PD-1) treatment for advanced non-small-cell lung cancer (NSCLC) has improved the survival of patients. However, a substantial percentage of patients do not respond to this treatment. We examined the use of DNA methylation...
LA  - en
PB  - Elsevier
KW  - Programmed Cell Death 1 Receptor
KW  - Progression-Free Survival
KW  - Proportional Hazards Models
KW  - Repressor Proteins
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents, Immunological
KW  - Biomarkers, Tumor
KW  - Carcinoma, Non-Small-Cell Lung
KW  - DNA Methylation
KW  - Epigenomics
KW  - Female
KW  - Forkhead Transcription Factors
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Nivolumab
KW  - Predictive Value of Tests
KW  - Retrospective Studies
KW  - Treatment Outcome
TI  - Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis.
TY  - research article
VL  - 6
ER  -